Concepedia

Sujatha Muralidharan

SM

Statistics

Publications

9

Citations

1.8K

H-Index

9

Active since

2011

Affiliations

Synta Pharmaceuticals (United States)(Current)

Boston University

University of Massachusetts Chan Medical School

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Universitat de Barcelona

Sujatha Muralidharan is an author at Synta Pharmaceuticals (United States) specializing in life sciences, immunology, and inflammatory signaling.

ORCID

Publications per year

2011–2022

9

Publications

9

Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice

José J. Fuster, Susan MacLauchlan, María A. Zuriaga et al. · Science · 2017 · 1.5K citations · Full text

, , +17

Moderate Alcohol Induces Stress Proteins HSF1 and hsp70 and Inhibits Proinflammatory Cytokines Resulting in Endotoxin Tolerance

Sujatha Muralidharan, Aditya Ambade, Melissa A. Fulham et al. · The Journal of Immunology · 2014 · 81 citations · Full text

, , +17

Activation of Wnt Signaling Arrests Effector Differentiation in Human Peripheral and Cord Blood-Derived T Lymphocytes

Sujatha Muralidharan, Patrick J. Hanley, Enli Liu et al. · The Journal of Immunology · 2011 · 70 citations · Full text

, , +17

Low-dose radiation affects cardiac physiology: gene networks and molecular signaling in cardiomyocytes

Matthew A. Coleman, Sharath P. Sasi, Jillian Onufrak et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2015 · 57 citations · Full text

, , +17

Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis

Marc Corbera‐Bellalta, Roser Alba-Rovira, Sujatha Muralidharan et al. · Annals of the Rheumatic Diseases · 2022 · 55 citations · Full text

, , +17

1–5 of 9